BrainScope Gets FDA Approval for Traumatic Brain Injury Assessment Tech; Michael Singer Comments
BrainScope has received marketing clearance from the Food and Drug Administration for a medical device the neurotechnology company designed to help clinicians examine traumatic brain injury cases. Bethesda, Maryland-based BrainScope said Monday it developed the Ahead 300 multi-modal device in collaboration with the Defense Department. “FDA clearance of the Ahead 300 is a bellwether moment in our company’s […] More